Cargando…
Chronic Myeloid Leukemia in a Patient with Previous Idiopathic Thrombocytopenic Purpura: How to Manage Imatinib Together with Eltrombopag
The occurrence of chronic myeloid leukemia (CML), or other myeloproliferative diseases, after the development of idiopathic thrombocytopenic purpura (ITP) is very rare in the current medical literature. Considering the advances in ITP management, and the wide use of new drugs for ITP and CML, we rep...
Autores principales: | Autore, Francesco, Sora’, Federica, Chiusolo, Patrizia, Minnella, Gessica, Colangelo, Maria, Rossi, Elena, Sica, Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708281/ https://www.ncbi.nlm.nih.gov/pubmed/34946271 http://dx.doi.org/10.3390/medicina57121326 |
Ejemplares similares
-
Treatment of immune thrombocytopenic purpura: focus on eltrombopag
por: Rice, Lawrence
Publicado: (2009) -
Steroid-Refractory Chronic Idiopathic Thrombocytopenic Purpura Responding to Combination Therapy With Eltrombopag and Rituximab
por: Ahmed, Mohanad, et al.
Publicado: (2020) -
Low-Dose Eltrombopag in a Patient with Chronic Idiopathic Thrombocytopenic Purpura Post Sleeve Gastrectomy
por: Ahmed, Mohanad A., et al.
Publicado: (2020) -
Eltrombopag Dose Adjustment During Infection-Induced Thrombocytosis in a Patient With Chronic Idiopathic Thrombocytopenic Purpura
por: Ahmed, Mohanad, et al.
Publicado: (2021) -
Idiopathic thrombocytopenic purpura
por: Kayal, L., et al.
Publicado: (2014)